CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ATOSSA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,851
-41.5%
45,9620.0%0.00%
Q2 2023$57,912
+73.8%
45,9620.0%0.00%
Q1 2023$33,318
+37.2%
45,9620.0%0.00%
Q4 2022$24,291
-37.7%
45,9620.0%0.00%
Q3 2022$39,000
-23.5%
45,9620.0%0.00%
Q2 2022$51,000
-87.0%
45,962
-85.4%
0.00%
Q1 2022$393,000
-18.1%
313,912
+4.8%
0.00%
Q4 2021$480,000
-50.9%
299,4310.0%0.00%
Q3 2021$977,000
-47.4%
299,431
+1.9%
0.00%
-100.0%
Q2 2021$1,858,000
+3103.4%
293,958
+976.5%
0.00%
Q1 2021$58,00027,3080.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Ahrens Investment Partners LLC 10,000$26,0000.01%
PNC FINANCIAL SERVICES GROUP, INC. 66$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 100$00.00%
GEODE CAPITAL MANAGEMENT, LLC 89,903$229,0000.00%
DEUTSCHE BANK AG\ 300$00.00%
MORGAN STANLEY 1,910$5,0000.00%
BlackRock Inc. 669$2,0000.00%
Citadel Advisors 17,000$43,0000.00%
Citadel Advisors 10,298$26,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders